Pharmasset Articles

Gilead expands hepatitis C R&D portfolio with $11 billion buy of Pharmasset

22 November 2011

Bristol-Myers Squibb collaborates with Pharmasset on combo hep C drug trial

11 January 2011

Showing 1-2 of 2 articles

Go to beginningPrevious
  • 1
NextGo to end